• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines

Recent Advances in the Study of (5-(m-Tolyl)pyridin-3-yl)methanol (CAS: 887974-04-1) in Chemical Biology and Pharmaceutical Research

The compound (5-(m-Tolyl)pyridin-3-yl)methanol, with the CAS number 887974-04-1, has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its pyridine core and m-tolyl substituent, has shown promising potential in various applications, including drug discovery, medicinal chemistry, and biochemical studies. Recent studies have focused on its synthesis, structural modifications, and biological activities, making it a compound of interest for researchers aiming to develop novel therapeutic agents.

One of the key areas of research involving (5-(m-Tolyl)pyridin-3-yl)methanol is its role as an intermediate in the synthesis of more complex bioactive molecules. Recent publications have highlighted its utility in the construction of heterocyclic compounds, which are often pivotal in drug design due to their diverse pharmacological properties. For instance, a 2023 study demonstrated the efficient conversion of this compound into various pyridine derivatives, which exhibited notable activity against specific enzyme targets involved in inflammatory pathways.

In addition to its synthetic applications, (5-(m-Tolyl)pyridin-3-yl)methanol has been investigated for its direct biological effects. Preliminary in vitro studies have indicated that this compound may possess anti-inflammatory and antimicrobial properties. A recent report published in the Journal of Medicinal Chemistry detailed its inhibitory effects on certain bacterial strains, suggesting its potential as a lead compound for developing new antibiotics. Furthermore, molecular docking studies have revealed that the compound can interact with key residues in bacterial enzymes, providing a structural basis for its activity.

Another significant aspect of research on (5-(m-Tolyl)pyridin-3-yl)methanol revolves around its pharmacokinetic properties. A 2024 study explored its metabolic stability and bioavailability, which are critical factors in drug development. The findings indicated that the compound exhibits moderate metabolic stability in human liver microsomes, with a half-life that could be optimized through structural modifications. These insights are invaluable for medicinal chemists working to enhance the drug-like properties of this scaffold.

Recent advancements in analytical techniques have also facilitated a deeper understanding of (5-(m-Tolyl)pyridin-3-yl)methanol. High-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy have been employed to elucidate its structural features and purity, ensuring its reliable use in further studies. Additionally, computational chemistry approaches, such as density functional theory (DFT) calculations, have provided insights into its electronic properties and reactivity, aiding in the design of derivatives with improved efficacy.

In conclusion, (5-(m-Tolyl)pyridin-3-yl)methanol (CAS: 887974-04-1) represents a versatile and promising compound in the realm of chemical biology and pharmaceutical research. Its applications span from synthetic chemistry to direct biological activity, with ongoing studies continually uncovering new potentials. As research progresses, this compound is likely to play a pivotal role in the development of novel therapeutic agents, underscoring the importance of continued investigation into its properties and applications.

• 85553-54-4(3-(pyridin-3-yl)phenylmethanol)
• 217189-04-3((4-Pyrid-3-ylphenyl)methanol)
• 887974-10-9((5-(p-Tolyl)pyridin-3-yl)methanol)
• 887974-27-8((5-(o-Tolyl)pyridin-3-yl)methanol)
• 187392-96-7((5-Phenylpyridin-3-yl)methanol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)